Zinc induces neurofilament phosphorylation independent of p70 S6 kinase in N2a cells
- PMID: 15812314
- DOI: 10.1097/00001756-200504250-00015
Zinc induces neurofilament phosphorylation independent of p70 S6 kinase in N2a cells
Abstract
Hyperphosphorylated neurofilaments are a part of neurofibrillary tangles in Alzheimer's disease brains. Zinc has been shown to be increased in the brain areas heavily affected by Alzheimer pathologies. Zinc could induce tau hyperphosphorylation in SH-SY5Y and N2a cells, and tau phosphorylation may be mediated by p70 S6 kinase activation. Many of the tau kinases can also phosphorylate neurofilaments, and in this study we wanted to see whether neurofilament phosphorylation is regulated by p70 S6 kinase in N2a cells. We found that zinc induces rapamycin-dependent p70 S6 kinase phosphorylation at Thr421/Ser424 and Thr389, and rapamycin-independent phosphorylation of neurofilaments at the SMI34 epitope. Although zinc could induce cell proliferation and cell growth, and increased phosphorylation of neurofilaments, only cell growth appeared to be related to p7056kinase activation.
Similar articles
-
Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.Am J Pathol. 2003 Aug;163(2):591-607. doi: 10.1016/S0002-9440(10)63687-5. Am J Pathol. 2003. PMID: 12875979 Free PMC article.
-
Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells.J Neurochem. 2005 Mar;92(5):1104-15. doi: 10.1111/j.1471-4159.2004.02948.x. J Neurochem. 2005. PMID: 15715661
-
P70 S6 kinase mediates tau phosphorylation and synthesis.FEBS Lett. 2006 Jan 9;580(1):107-14. doi: 10.1016/j.febslet.2005.11.059. Epub 2005 Dec 6. FEBS Lett. 2006. PMID: 16364302
-
p70 S6 kinase and tau in Alzheimer's disease.J Alzheimers Dis. 2008 Aug;14(4):385-92. doi: 10.3233/jad-2008-14405. J Alzheimers Dis. 2008. PMID: 18688088 Review.
-
Cyclin-dependent kinase 5 in neurofilament function and regulation.Neurosignals. 2003 Sep-Oct;12(4-5):252-64. doi: 10.1159/000074627. Neurosignals. 2003. PMID: 14673212 Review.
Cited by
-
Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: implication for Alzheimer disease.J Biol Chem. 2013 May 31;288(22):15556-70. doi: 10.1074/jbc.M112.435123. Epub 2013 Apr 12. J Biol Chem. 2013. PMID: 23585566 Free PMC article.
-
Alternative Pharmacological Strategies for the Treatment of Alzheimer's Disease: Focus on Neuromodulator Function.Biomedicines. 2022 Nov 28;10(12):3064. doi: 10.3390/biomedicines10123064. Biomedicines. 2022. PMID: 36551821 Free PMC article. Review.
-
Effects of BD1047, a σ1 receptor antagonist, on the expression of mTOR, Camk2γ and GSK-3β in fluvoxamine-treated N2a cells.Exp Ther Med. 2014 Feb;7(2):435-438. doi: 10.3892/etm.2013.1438. Epub 2013 Dec 5. Exp Ther Med. 2014. PMID: 24396420 Free PMC article.
-
Environmental factors in the development and progression of late-onset Alzheimer's disease.Neurosci Bull. 2014 Apr;30(2):253-70. doi: 10.1007/s12264-013-1425-9. Epub 2014 Mar 24. Neurosci Bull. 2014. PMID: 24664867 Free PMC article. Review.
-
Pharmacotherapeutic targets in Alzheimer's disease.J Cell Mol Med. 2009 Jan;13(1):61-86. doi: 10.1111/j.1582-4934.2008.00595.x. Epub 2008 Nov 18. J Cell Mol Med. 2009. PMID: 19040415 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources